Get started
Author

Francesco Giuseppe Carbone

Observed names: Carbone, Francesco Giuseppe, FRANCESCO GIUSEPPE CARBONE, Francesco Carbone, Francesco G. Carbone
ORCID: 0000-0001-8425-9658
Observed ORCID: 0000-0001-8425-9658
OpenAlex ID: A5068675529
The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore
2023 · Paola Parente, Federica Grillo, et al. · Digestive Diseases · 49
PDF
Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
2020 · Angelo Castello, Francesco Giuseppe Carbone, et al. · Cancers · 44
PDF
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer
2024 · Alessandro Alaimo, Sacha Genovesi, et al. · The EMBO Journal · 28
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors
2020 · Alessandro Alaimo, Marco Lorenzoni, et al. · Cell Death and Disease · 28
Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature
2018 · ANGIOLO GADDUCCI, SABINA PISTOLESI, et al. · Anticancer Research · 27
PDF
Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies
2022 · Sacha Genovesi, Riccardo Moro, et al. · Biomolecules · 18
PDF
TRPM8 protein expression in hormone naïve local and lymph node metastatic prostate cancer
2021 · Andrea Lunardi, Mattia Barbareschi, et al. · Pathologica · 14
PDF
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations
2024 · Alessandro D’Ambrosio, Davide Bressan, et al. · Science Advances · 13
PDF
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation
2022 · Marco Lorenzoni, Dario De Felice, et al. · Cancer Letters · 13
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
2024 · Valeria Merz, Francesca Maines, et al. · Journal of Cancer Research and Clinical Oncology · 7
The clinical impact of precise assessment of predictive biomarkers in gastroesophageal cancer: focus on the PD-L1 combined positive score (CPS) and tumor area positivity (TAP) systems
2026 · Alessandro Gambella, Valentina Angerilli, et al. · Pathologica · 3
Adequacy criteria and reporting for prognostic and predictive profiling of biopsies from gastrointestinal neoplasia: A position paper from the Italian group of gastrointestinal pathologists, section of Italian society of anatomic pathology and cytology (GIPAD-SIAPeC-IAP)
2026 · Paola Parente, Federica Grillo, et al. · Digestive and Liver Disease · 2
TRPM8 levels determine tumor vulnerability to channel agonists
2025 · Alessandro Alaimo, Francesco Giuseppe Carbone, et al. · Molecular Oncology · 2
PDF
Editorial: Cholangiocarcinoma a New Multimodality Approach
2022 · Fabrizio Bronte, Sandro Sferrazza, et al. · Frontiers in Oncology · 2
PDF
Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall
2020 · Luca Cima, Nicola Mirabassi, et al. · International Journal of Surgical Pathology · 1
PDF
Supplementary Table S2 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Table S5 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Figure S1 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Figure S2 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Figure S4 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Figure S3 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Table S6 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Figure S5 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Table S3 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Supplementary Table S7 from ERG Orchestrates a Dedifferentiation–Senescence–Inflammation Triad in Prostate Cancer
2026 · Francesca Lorenzin, Giulia Fracassi, et al.
Works count: 36
Citation count: 251
H-index: 9
I10-index: 9
Year
Topic
Type